Press Release: Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

Dow Jones
01-10

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

INDIANAPOLIS--(BUSINESS WIRE)--January 09, 2025-- 

Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

   -- 
 888-947-9963 -- Access Code - 3972058 (Domestic) 
 
 
   -- 
 312-470-0178 -- Access Code - 3972058 (International) 
 
 
   -- 
 866-405-7292 -- No Access Code (Domestic Replay) 
 
 
   -- 
 203-369-0604 -- No Access Code (International Replay) 
 

The replay will be available from 11:30 a.m. EST on January 23, 2025, until the end of the day on February 21, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also access the webcast here. A webcast replay will be available following the call.

About Elevance Health

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey -- connecting them to the care, support, and resources they need to lead better lives. Elevance Health's companies serve approximately 113 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250109948306/en/

 
    CONTACT:    Investor Relations: 

Nathan Rich

Investor.Relations@elevancehealth.com

Media Relations:

Leslie Porras

Leslie.Porras@elevancehealth.com

 
 

(END) Dow Jones Newswires

January 09, 2025 16:08 ET (21:08 GMT)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10